Can-Fite BioPharma Ltd. has announced an At The Market Offering Agreement with H.C. Wainwright & Co. on August 30, 2024, allowing for the sale of up to $9 million in American Depositary Shares. The offering will occur through various methods, including at-the-market sales and is effective under the previously filed registration statement with the SEC.